News

Rockwell Medical is a biopharmaceutical company that offers products and services initially targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia. The company is

In a pivotal randomized, double-blind Phase 3 study, the drug has shown improvement in overall survival based on results. In the trial, the median overall survival was 10

The company has posted loss from operations of $7.03m, compared to $14.15m for the comparable period in 2009. For the full year ended 31 December 2010, the company

Xyzal, an antihistamine, is a prescription medication indicated for the symptoms of year round allergies, as well as a treatment for chronic hives and rashes of unknown cause

The primary endpoint of the trial is to determine the safety, tolerability and pharmacokinetics of the drug, although the design allows the collection of efficacy data as well.

The Phase III multinational, randomized, double-blind, double-dummy, placebo-controlled trial enrolled 565 postmenopausal women with established osteoporosis in six countries. The study’s primary endpoint was the percent change in

In clinical studies, Zyclara cream cleared genital warts safely and effectively in about eight weeks. In addition, data showed that of those patients who achieved complete clearance, only

The company is organizing two pivotal prospective, randomized, double-blinded, placebo-controlled, multicenter study Phase III trials CRUISE-1 and CRUISE-2. Each study expects to recruit around 300 patients, randomized equally

Zostavax, which is manufactured by Merck, was originally approved by the FDA for the prevention of shingles in individuals 60 years of age and older. The approval was